Antituberculous Drug Resistance in Manitoba from 1980 to 1989

Overview

Journal CMAJ

Date 1993 May 1

PMID 8477367

Citations 9

Authors

R Long

J Manfreda

L Mendella

J Wolfe

S Parker

E Hershfield

Affiliations

Soon will be listed here.

Abstract

Objectives: To estimate the magnitude of antituberculous drug resistance and identify the risk factors for its development in tuberculosis patients in Manitoba over a 10-year period. As well, to examine the clinical course of the patients whose initial or subsequent isolates of Mycobacterium tuberculosis were resistant to one or more drugs.

Design: Comparison of drug-resistant and non-drug-resistant cases of tuberculosis.

Setting: Manitoba.

Patients: All people with tuberculosis reported to the Central Tuberculosis Registry of Manitoba between Jan. 1, 1980, and Dec. 31, 1989.

Main Outcome Measures: Of 1478 cases of active tuberculosis 1086 were culture positive, and drug susceptibility testing was performed in these cases. The clinical course, including outcome of treatment, of all drug-resistant cases was described.

Results: Of 1086 culture-positive cases of tuberculosis 77 (7.1%) were drug resistant. Odds ratios suggested that the risk of drug resistance was significantly higher among the immigrants than among the other Canadians. Compared with the other Canadians the risk of drug resistance was 9.9 times greater among the immigrants in whom tuberculosis developed within the first year after arrival in Canada and 5.4 times greater among the immigrants in whom it developed 2 to 5 years after arrival in Canada. Of the 71 patients with drug-resistant disease whose type of resistance was known 62% had never taken antituberculous drugs before and 38% had. Most (91%) of the 77 cases of drug-resistant disease were resistant to first-line drugs, especially isoniazid and streptomycin. Thirty-two (42%) of the 77 cases were resistant to two or more first-line drugs. Of patients with drug-resistant disease a subgroup of 10 had disease that became resistant to several drugs over the 10-year period. The outcome of treatment in these individuals was poor, and they presented a particular public health problem.

Conclusion: Resistance to one or more first-line antituberculous drugs continues to complicate the treatment of tuberculosis and may facilitate the spread of the disease.

Citing Articles

Dimensions of poverty as risk factors for antimicrobial resistant organisms in Canada: a structured narrative review.

King T, Schindler R, Chavda S, Conly J Antimicrob Resist Infect Control. 2022; 11(1):18.

PMID: 35074013 PMC: 8785485. DOI: 10.1186/s13756-022-01059-1.

Screening and treatment of immigrants and refugees to Canada for tuberculosis: Implications of the experience of Canada and other industrialized countries.

Thomas R, Gushulak B Can J Infect Dis. 2012; 6(5):246-55.

PMID: 22514407 PMC: 3327927. DOI: 10.1155/1995/271936.

Dash for DOT.

Shafran S, Conly J Can J Infect Dis. 2012; 6(5):233-4.

PMID: 22514403 PMC: 3327930. DOI: 10.1155/1995/587969.

The impact of global tuberculosis in Canada: We are our brothers' keepers.

Fanning E Can J Infect Dis. 2012; 6(5):225-7.

PMID: 22514400 PMC: 3327935. DOI: 10.1155/1995/934971.

Tuberculosis drug resistance in Canada, 1998 to 2000.

Phypers M, Panaro L, Nault P Can J Infect Dis. 2007; 12(3):141-3.

PMID: 18159330 PMC: 2094809. DOI: 10.1155/2001/148487.

References

Fox W . Compliance of patients and physicians: experience and lessons from tuberculosis-I. Br Med J (Clin Res Ed). 1983; 287(6384):33-5. PMC: 1548153. DOI: 10.1136/bmj.287.6384.33. View

Armstrong A . The prevalence in Canada of drug-resistant tubercle bacilli in newly discovered untreated patients with tuberculosis. Can Med Assoc J. 2010; 94(9):420-5. PMC: 1935312. View

CROFTON J . The prevention and management of drug-resistant tuberculosis. Bull Int Union Tuberc Lung Dis. 1987; 62(1-2):6-11. View

EIDUS L, Jessamine A, Hershfield E, Helbecque D . A national study to determine the prevalence of drug resistance in newly discovered previously untreated tuberculosis patients as well as in retreatment cases. Can J Public Health. 1978; 69(2):146-53. View

Enarson D, Grzybowski S . Incidence of active tuberculosis in the native population of Canada. CMAJ. 1986; 134(10):1149-52. PMC: 1491042. View

Daley C, Small P, Schecter G, Schoolnik G, McAdam R, Jacobs Jr W . An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992; 326(4):231-5. DOI: 10.1056/NEJM199201233260404. View

Iseman M, Madsen L . Drug-resistant tuberculosis. Clin Chest Med. 1989; 10(3):341-53. View

Di Perri G, Cruciani M, Danzi M, Luzzati R, De Checchi G, Malena M . Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet. 1989; 2(8678-8679):1502-4. View

Enarson D, Ashley M, Grzybowski S . Tuberculosis in immigrants to Canada. A study of present-day patterns in relation to immigration trends and birthplace. Am Rev Respir Dis. 1979; 119(1):11-8. DOI: 10.1164/arrd.1979.119.1.11. View

10.

Enarson D, Grzybowski S, Dorken E . Failure of diagnosis as a factor in tuberculosis mortality. Can Med Assoc J. 1978; 118(12):1520-2. PMC: 1818119. View

11.

Sbarbaro J . Compliance: inducements and enforcements. Chest. 1979; 76(6 Suppl):750-6. DOI: 10.1378/chest.76.6_supplement.750. View

12.

Chawla P, Klapper P, Kamholz S, Pollack A, Heurich A . Drug-resistant tuberculosis in an urban population including patients at risk for human immunodeficiency virus infection. Am Rev Respir Dis. 1992; 146(2):280-4. DOI: 10.1164/ajrccm/146.2.280. View

13.

Iseman M, Sbarbaro J . Compliance and tuberculosis treatment. Lancet. 1991; 337(8757):1609. DOI: 10.1016/0140-6736(91)93306-t. View

14.

Scalcini M, Carre G, Jean-Baptiste M, Hershfield E, Parker S, Wolfe J . Antituberculous drug resistance in central Haiti. Am Rev Respir Dis. 1990; 142(3):508-11. DOI: 10.1164/ajrccm/142.3.508. View

15.

Fischl M, Uttamchandani R, Daikos G, Poblete R, Moreno J, Reyes R . An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann Intern Med. 1992; 117(3):177-83. DOI: 10.7326/0003-4819-117-3-177. View